Using UNC's expertise to fight emerging diseases

Fri Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Share: Facebook | Twitter | Email

Related: Campus Connections

Recent Campus Connections News:

How Carolina is transforming medicine with artificial intelligence
Wednesday September 19, 2018

For 30 years, Stone Center has been bringing people together
Wednesday September 19, 2018

Great college football (and foodie) towns to visit this fall
Tuesday September 18, 2018

Hurricane Florence: How to support the recovery efforts
Sunday September 16, 2018

UNC-Chapel Hill to host shelter to serve people displaced by Hurricane Florence
Saturday September 15, 2018